Cervical cancer drug raises survival rate by 30% compared to chemotherapy: ‘Game-changer’

2 years ago 33

The prescription medicine TIVDAK is showing positive results for treating cervical cancer after a phase 3 trial. Drs. Brian Slomovitz and Kathleen Moore reveal its efficacy and potential.

1. Homepage
2. National News
3. Cervical cancer drug raises survival rate by 30% compared to chemotherapy: ‘Game-changer’